Effects of Low-Flow Sevoflurane Anesthesia on Pulmonary Function During One-Lung Ventilation
Launched by DR ABDURRAHMAN YURTASLAN ANKARA ONCOLOGY TRAINING AND RESEARCH HOSPITAL · Jul 24, 2025
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a specific type of anesthesia called low-flow sevoflurane affects lung function during and after surgery on the chest, where only one lung is used for breathing (this is called one-lung ventilation). The goal is to see if using low-flow anesthesia, which uses less gas, helps the lungs work better and reduces breathing problems after surgery compared to the usual amount of anesthesia gas.
The study will include adults aged 18 to 75 who are having planned chest surgery, such as minimally invasive procedures or open surgery, and who are generally healthy enough for surgery without severe lung or heart problems. Participants will receive either low-flow or standard anesthesia during their surgery, and the doctors will monitor their lung function and oxygen levels during and after the operation. This research could help improve anesthesia methods to make recovery easier and safer for future patients having similar chest surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 75 years American Society of Anesthesiologists (ASA) physical status I-III Scheduled for elective video-assisted thoracoscopic surgery (VATS) or thoracotomy No acute respiratory failure
- Exclusion Criteria:
- • Severe chronic obstructive pulmonary disease (COPD) or restrictive lung disease Body mass index (BMI) greater than 40 kg/m² Cardiac dysfunction with ejection fraction (EF) less than 40% Requirement for emergency thoracic surgery
About Dr Abdurrahman Yurtaslan Ankara Oncology Training And Research Hospital
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital is a leading institution dedicated to advancing cancer care and research in Turkey. With a strong focus on innovative oncology treatments and comprehensive training programs, the hospital serves as a pivotal center for clinical trials aimed at improving patient outcomes. Its multidisciplinary team of specialists collaborates to explore cutting-edge therapeutic approaches, ensuring adherence to the highest standards of clinical research and patient safety. The hospital's commitment to excellence positions it as a key player in the global oncology research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported